title: Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.
authors.affiliation: Division of Medical Oncology University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA.
authors.forename: Thomas
authors.initials: T
authors.lastname: Winder
authors.forename: Wu
authors.initials: W
authors.lastname: Zhang
authors.forename: Dongyun
authors.initials: D
authors.lastname: Yang
authors.forename: Yan
authors.initials: Y
authors.lastname: Ning
authors.forename: Pierre
authors.initials: P
authors.lastname: Bohanes
authors.forename: Armin
authors.initials: A
authors.lastname: Gerger
authors.forename: Peter M
authors.initials: PM
authors.lastname: Wilson
authors.forename: Alexandra
authors.initials: A
authors.lastname: Pohl
authors.forename: David J
authors.initials: DJ
authors.lastname: Mauro
authors.forename: Christiane
authors.initials: C
authors.lastname: Langer
authors.forename: Eric K
authors.initials: EK
authors.lastname: Rowinsky
authors.forename: Heinz-Josef
authors.initials: HJ
authors.lastname: Lenz